Campbell, CA, United States of America

Kevin Mitz

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin Mitz: Innovator in Pulmonary Treatment Devices

Introduction

Kevin Mitz is a notable inventor based in Campbell, California. He has made significant contributions to the field of pulmonary treatment through his innovative designs and methods. His work focuses on addressing the challenges faced by patients with advanced Chronic Obstructive Pulmonary Disease (COPD).

Latest Patents

Kevin Mitz holds a patent for "Devices, treatments and methods to restore tissue elastic recoil." This patent outlines pulmonary treatment devices, systems, and methods specifically designed to treat the compromised lung tissues of advanced COPD sufferers. The treatments aim to reduce trapped air volume, tension in lung tissue, and enhance lung elastic recoil. Various embodiments of the devices are provided, including those that move portions of lung tissue around a rotational axis into a torqued configuration, anchoring such tissue in place for improved breathing mechanics. He has 1 patent to his name.

Career Highlights

Kevin Mitz is associated with Free Flow Medical, Inc., where he continues to develop and refine his innovative pulmonary treatment devices. His work is crucial in improving the quality of life for patients suffering from severe lung conditions.

Collaborations

Kevin collaborates with talented individuals in his field, including Mark L. Mathis and Michael W. Lau. Their combined expertise contributes to the advancement of medical technologies aimed at enhancing respiratory health.

Conclusion

Kevin Mitz is a pioneering inventor whose work in pulmonary treatment devices is making a significant impact on the lives of COPD patients. His innovative approaches and dedication to improving lung health are commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…